Department for Health Services Research, Carl von Ossietzky University of Oldenburg, Ammerländer Heerstr. 114-118, 26129, Oldenburg, Germany.
J Artif Organs. 2020 Dec;23(4):303-314. doi: 10.1007/s10047-020-01170-3. Epub 2020 May 4.
Since the first use of a ventricular assist device in 1963 many extracorporeal and implantable pulsatile blood pumps have been developed. After the invention of continuous flow blood pumps the implantable pulsatile pumps are not available anymore. The new rotary pumps spend a better quality of life because many of the patients can go home. Nevertheless, the extracorporeal pulsatile pumps have some advantages. They are low-cost systems, produce less haemolysis and heart-recovery can be tested easily. Pump failure is easy to realize because the pumps can be observed visually. Pump exchange can be done easily without any chirurgic surgery. As volume displacement pumps they can produce high blood pressure, so they are the only ones suitable for pediatric patients. Therefore, they are indispensable for clinical use today and in the future. In this work, nearly all pulsatile blood pumps used in clinical life are described.
自 1963 年首次使用心室辅助装置以来,已经开发出许多体外和植入式搏动血泵。在发明连续流动血泵之后,植入式搏动泵已不再使用。新型旋转泵可提高生活质量,因为许多患者可以回家。然而,体外搏动泵具有一些优势。它们是低成本系统,产生的溶血较少,并且易于测试心脏恢复情况。由于可以通过目视观察到泵,因此很容易发现泵故障。无需进行任何外科手术即可轻松更换泵。作为容积置换泵,它们可以产生高压,因此它们是唯一适合儿科患者的泵。因此,它们在今天和将来的临床应用中都是不可或缺的。在这项工作中,描述了几乎所有在临床实践中使用的搏动血泵。